Lanadelumab for Treatment of COVID-19 Disease

NCT04422509 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

43

Enrollment

OTHER

Sponsor class

Conditions

COVID-19

Interventions

BIOLOGICAL: lanadelumab
OTHER: regular care

Sponsor

Radboud University Medical Center

Collaborators

[object Object]